"In 2017, the U.S. Department of Health and Human Services (HHS) announced a public health emergency due to an increase in the misuse of opioids. The administration introduced a strategic framework called the Five-Point Opioid Strategy, which includes providing access recovery services, increasing the availability of reversing agents for overdose, funding opioid misuse and pain research, changing treatments of people managing pain, and updating public health reports related to combating opioid drug misuse.The US epidemic in the 2000s is related to a number of factors. Rates of opioid use and dependency vary by age, sex, race, and socioeconomic status. With respect to race the discrepancy in deaths is thought to be due to an interplay between physician prescribing and lack of access to healthcare and certain prescription drugs. Men are at higher risk for opioid use and dependency than women, and men also account for more opioid overdoses than women, although this gap is closing. Women are more likely to be prescribed pain relievers, be given higher doses, use them for longer durations, and may become dependent upon them faster.Deaths due to opioid use also tend to skew at older ages than deaths from use of other illicit drugs. This does not reflect opioid use as a whole, which includes individuals in younger age demographics. Overdoses from opioids are highest among individuals who are between the ages of 40 and 50, in contrast to heroin overdoses, which are highest among individuals who are between the ages of 20 and 30.
Dysequilibrium syndrome may refer to:

Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 1 (CAMRQ1), an autosomal recessive cerebellar ataxia associated with the VLDLR gene
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2 (CAMRQ2), an autosomal recessive cerebellar ataxia associated with the WDR81 gene
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CAMRQ3), an autosomal recessive cerebellar ataxia associated with the CA8 gene
Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4 (CAMRQ4), an autosomal recessive cerebellar ataxia associated with the ATP8A2 gene